Flurazepam dihydrochloride structure
|
Common Name | Flurazepam dihydrochloride | ||
---|---|---|---|---|
CAS Number | 1172-18-5 | Molecular Weight | 460.80000 | |
Density | N/A | Boiling Point | 551.4ºC at 760mmHg | |
Molecular Formula | C21H25Cl3FN3O | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 287.2ºC | |
Symbol |
GHS07, GHS08 |
Signal Word | Warning |
Name | Flurazepam Dihydrochloride |
---|---|
Synonym | More Synonyms |
Boiling Point | 551.4ºC at 760mmHg |
---|---|
Molecular Formula | C21H25Cl3FN3O |
Molecular Weight | 460.80000 |
Flash Point | 287.2ºC |
Exact Mass | 459.10500 |
PSA | 35.91000 |
LogP | 5.10950 |
Appearance of Characters | solid | light yellow |
Vapour Pressure | 3.34E-12mmHg at 25°C |
Storage condition | 2-8°C |
Water Solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: <6 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H373 |
Precautionary Statements | P260-P301 + P312 + P330 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R22 |
Safety Phrases | S1/2-S22-S36-S36/37/39 |
RIDADR | 3249 |
WGK Germany | 3 |
RTECS | DF0875000 |
Packaging Group | III |
Hazard Class | 6.1(b) |
Precursor 0 | |
---|---|
DownStream 2 | |
Folie à deux: a case report.
Clin. Schizophr. Relat. Psychoses 7(2) , 93-6, (2013) Folie à deux is a relatively rare mental disorder first described in France in 1877 by Lasègue and Falret. However, folie à deux is still a matter of study and debate today as it remains a challenge f... |
|
LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
Methods Mol. Biol. 603 , 89-105, (2010) We describe a single method for the detection and quantitation of 13 commonly prescribed benzodiazepines and metabolites: alpha-hydroxyalprazolam, alpha-hydroxyethylflurazepam, alpha-hydroxytriazolam,... |
|
Gender differences in highway driving performance after administration of sleep medication: a review of the literature.
Traffic Inj. Prev. 13(3) , 286-92, (2012) It is generally assumed that there are minimal gender differences in the safety and efficacy of central nervous system drugs, as is evidenced by men and women receiving the same drug dosage. There is,... |
7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one,dihydrochloride |
EINECS 214-630-0 |
MFCD00058189 |